Alker, W., Haase, H., 2018. Zinc and sepsis. Nutrients 10, 1–17. https://doi.org/10.3390/nu10080976
Amiya, T., Nakamoto, N., Chu, P.S., Teratani, T., Nakajima, H., Fukuchi, Y., Taniki, N., Yamaguchi, A., Shiba, S., Miyake, R., Katayama, T., Ebinuma, H., Kanai, T., 2016. Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin Ainduced murine liver injury via CCR9 axis. Sci. Rep. 6, 1–12. https://doi.org/10.1038/srep35146
Bao, B., Prasad, A.S., Beck, F.W.J., Fitzgerald, J.T., Snell, D., Bao, G.W., Singh, T., Cardozo, L.J., 2010. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am. J. Clin. Nutr. 91, 1634– 1641. https://doi.org/10.3945/ajcn.2009.28836
Berg, D.J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G., Rennick, D., 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96, 2339–2347. https://doi.org/10.1172/JCI118290
Boehm, M., Hepworth, D., Loria, P.M., Norquay, L.D., Filipski, K.J., Chin, J.E., Cameron, K.O., Brenner, M., Bonnette, P., Cabral, S., Conn, E., Ebner, D.C., Gautreau, D., Hadcock, J., Lee, E.C.Y., Mathiowetz, A.M., Morin, M., Rogers, L., Smith, A., Vanvolkenburg, M., Carpino, P. a., 2013. Chemical probe identification platform for orphan GPCRs using focused compound screening: GPR39 as a case example. ACS Med. Chem. Lett. 4, 1079–1084. https://doi.org/10.1021/ml400275z
Cassim, S., Bilodeau, M., Vincent, C., Lapierre, P., 2017. Novel Immunotherapies for Autoimmune Hepatitis. Front. Pediatr. 5, 1–8. https://doi.org/10.3389/fped.2017.00008
Chasapis, C.T., Spiliopoulou, C.A., Loutsidou, A.C., Stefanidou, M.E., 2012. Zinc and human health: An update. Arch. Toxicol. 86, 521–534. https://doi.org/10.1007/s00204-011-0775-1
Chaudhry, H., Zhou, J., Zhong, Y., Ali, M.M., McGuire, F., Nagarkatti, P.S., Nagarkatti, M., 2013. Role of cytokines as a double-edged sword in sepsis. In Vivo 27, 669–84.
Christen, U., Hintermann, E., Jaeckel, E., 2009. New animal models for autoimmune hepatitis. Semin. Liver Dis. 29, 262–272. https://doi.org/10.1055/s-0029-1233536
Davies, L.C., Jenkins, S.J., Allen, J.E., Taylor, P.R., 2013. Tissue-resident macrophages. Nat. Immunol. 14, 986–995. https://doi.org/10.1038/ni.2705
Dittmer, S., Golz, S., Pina, A.-L., Toutzaris, D., Saxena, A., Pantlen, A., Sahin, M., Methner, A., Geerts, A., 2008. The Constitutively Active Orphan G-protein-coupled Receptor GPR39 Protects from Cell Death by Increasing Secretion of Pigment Epithelium-derived Growth Factor. J. Biol. Chem. 283, 7074–7081. https://doi.org/10.1074/jbc.m704323200
Drucker, C., Gewiese, J., Malchow, S., Scheller, J., Rose-John, S., 2010. Impact of interleukin-6 classicand trans-signaling on liver damage and regeneration. J. Autoimmun. 34, 29–37. https://doi.org/10.1016/j.jaut.2009.08.003
Egerod, K.L., Holst, B., Petersen, P.S., Hansen, J.B., Mulder, J., Hökfelt, T., Schwartz, T.W., 2007. GPR39 Splice Variants Versus Antisense Gene LYPD1: Expression and Regulation in Gastrointestinal Tract, Endocrine Pancreas, Liver, and White Adipose Tissue. Mol. Endocrinol. 21, 1685–1698. https://doi.org/10.1210/me.2007-0055
Fink, M.P., 2014. Animal models of sepsis. Virulence 5, 143–153. https://doi.org/10.4161/viru.26083
Fjellström, O., Larsson, N., Yasuda, S., Tsuchida, T., Oguma, T., Marley, A., Wennberg-Huldt, C., Hovdal, D., Fukuda, H., Yoneyama, Y., Sasaki, K., Johansson, A., Lundqvist, S., Brengdahl, J., Isaacs, R.J., Brown, D., Geschwindner, S., Benthem, L., Priest, C., Turnbull, A., 2015. Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents. PLoS One 10, e0145849. https://doi.org/10.1371/journal.pone.0145849
Fleischmann, C., Scherag, A., Adhikari, N.K., Hartog, C.S., Tsaganos, T., Schlattmann, P., Angus, D.C., Reinhart, K., 2015. Global burden of sepsis: a systematic review. Crit. Care 19, P21. https://doi.org/10.1186/cc14081
Frimurer, T.M., Mende, F., Graae, A.-S., Engelstoft, M.S., Egerod, K.L., Nygaard, R., Gerlach, L.-O., Hansen, J.B., Schwartz, T.W., Holst, B., 2017. Model-Based Discovery of Synthetic Agonists for the Zn2+-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions. J. Med. Chem. 60, 886–898. https://doi.org/10.1021/acs.jmedchem.6b00648
Goto, M., Tanaka, Y., Murakawa, M., Kadoshima-Yamaoka, K., Inoue, H., Murafuji, H., Nagahira, A., Kanki, S., Hayashi, Y., Nagahira, K., Ogata, A., Miura, K., Nakatsuka, T., Chamoto, K., Fukuda, Y., Nishimura, T., 2009. Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice. Int. Immunopharmacol. 9, 1347–1351. https://doi.org/10.1016/j.intimp.2009.08.002
Hershfinkel, M., 2018. The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease. Int. J. Mol. Sci. 19, 439. https://doi.org/10.3390/ijms19020439
Holst, B., Egerod, K.L., Jin, C., Petersen, P.S., Østergaard, M.V., Hald, J., Sprinkel, A.M.E., Størling, J., Mandrup-Poulsen, T., Holst, J.J., Thams, P., Ørskov, C., Wierup, N., Sundler, F., Madsen, O.D., Schwartz, T.W., 2009. G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction. Endocrinology 150, 2577–2585. https://doi.org/10.1210/en.2008-1250 Holst, B., Egerod, K.L., Schild, E., Vickers, S.P., Cheetham, S., Gerlach, L.O., Storjohann, L., Stidsen, C.E., Jones, R., Beck-Sickinger, A.G., Schwartz, T.W., 2007. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148, 13–20. https://doi.org/10.1210/en.2006-0933
Kishimoto, T., Akira, S., Narazaki, M., Taga, T., 1995. Interleukin-6 family of cytokines and gp130. Blood 86, 1243–54.
Kitabayashi, C., Fukada, T., Kanamoto, M., Ohashi, W., Hojyo, S., Atsumi, T., Ueda, N., Azuma, I., Hirota, H., Murakami, M., Hirano, T., 2010. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int. Immunol. 22, 375–386. https://doi.org/10.1093/intimm/dxq017
Krawitt, E.L., 2006. Autoimmune hepatitis. N. Engl. J. Med. 354, 54–66. https://doi.org/10.1056/NEJMra050408
Lattin, J., Zidar, D.A., Schroder, K., Kellie, S., Hume, D.A., Sweet, M.J., 2007. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukoc. Biol. 82, 16–32. https://doi.org/10.1189/jlb.0107051
Li, H., Hu, D., Fan, H., Zhang, Y., LeSage, G.D., Caudle, Y., Stuart, C., Liu, Z., Yin, D., 2014. β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-triggered Inflammatory Signaling via Targeting p38 MAPK and Interleukin 10. J. Biol. Chem. 289, 23075–23085. https://doi.org/10.1074/jbc.M114.591495
Li, H., Wang, Y., Zhang, H., Jia, B., Wang, D., Li, H., Lu, D., Qi, R., Yan, Y., Wang, H., 2012. Yohimbine Enhances Protection of Berberine against LPS-Induced Mouse Lethality through Multiple Mechanisms. PLoS One 7, e52863. https://doi.org/10.1371/journal.pone.0052863
Lonergan, Z.R., Skaar, E.P., 2019. Nutrient Zinc at the Host–Pathogen Interface. Trends Biochem. Sci. 44, 1041–1056. https://doi.org/10.1016/j.tibs.2019.06.010
Louis, H., Le Moine, O., Peny, M.O., Quertinmont, E., Fokan, D., Goldman, M., Devière, J., 1997. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 25, 1382–1389. https://doi.org/10.1002/hep.510250614
Mahieu, T., Park, J.M., Revets, H., Pasche, B., Lengeling, A., Staelens, J., Wullaert, A., Vanlaere, I., Hochepied, T., van Roy, F., Karin, M., Libert, C., 2006. The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production. Proc. Natl. Acad. Sci. 103, 2292–2297. https://doi.org/10.1073/pnas.0510874103
Makita, N., Hizukuri, Y., Yamashiro, K., Murakawa, M., Hayashi, Y., 2015. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. Int. Immunol. 27, 131–141. https://doi.org/10.1093/intimm/dxu090
Malchow, S., Thaiss, W., Jänner, N., Waetzig, G.H., Gewiese-Rabsch, J., Garbers, C., Yamamoto, K., Rose-John, S., Scheller, J., 2011. Essential role of neutrophil mobilization in concanavalin Ainduced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling. Biochim. Biophys. Acta - Mol. Basis Dis. 1812, 290–301. https://doi.org/10.1016/j.bbadis.2010.11.009
Marshall, A., Lukk, M., Kutter, C., Davies, S., Alexander, G., Odom, D.T., 2013. Global Gene Expression Profiling Reveals SPINK1 as a Potential Hepatocellular Carcinoma Marker. PLoS One 8, e59459. https://doi.org/10.1371/journal.pone.0059459
Martin, G.S., Mannino, D.M., Eaton, S., Moss, M., 2003. The Epidemiology of Sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546–1554. https://doi.org/10.1056/NEJMoa022139
Matsuoka, S., Matsumura, H., Nakamura, H., Oshiro, S., Arakawa, Y., Hayashi, J., Sekine, N., Nirei, K., Yamagami, H., Ogawa, M., Nakajima, N., Amaki, S., Tanaka, N., Moriyama, M., 2009. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J. Clin. Biochem.
Nutr. 45, 292–303. https://doi.org/10.3164/jcbn.08-246 Mizuhara, H., O’Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., Fujiwara, H., 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179, 1529–37.
Młyniec, K., Budziszewska, B., Holst, B., Ostachowicz, B., Nowak, G., 2015. GPR39 (Zinc Receptor) Knockout Mice Exhibit Depression-Like Behavior and CREB/BDNF Down-Regulation in the Hippocampus. Int. J. Neuropsychopharmacol. 18, 1–8. https://doi.org/10.1093/ijnp/pyu002
Młyniec, K., Trojan, E., Ślusarczyk, J., Głombik, K., Basta-Kaim, A., Budziszewska, B., Skrzeszewski, J., Siwek, A., Holst, B., Nowak, G., 2016. Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder. J. Neuroimmunol. 291, 11–17. https://doi.org/10.1016/j.jneuroim.2015.12.001
Nicoletti, F., Di Marco, R., Zaccone, P., Salvaggio, A., Magro, G., Bendtzen, K., Meroni, P., 2000. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 32, 728–33. https://doi.org/10.1053/jhep.2000.17701
Nishida, K., 2013. [New knowledge from past decade: role of zinc in immune system]. Nihon Eiseigaku Zasshi. 68, 145–152. https://doi.org/10.1265/jjh.68.145
Ohkawara, T., Takeda, H., Kato, K., Miyashita, K., Kato, M., Iwanaga, T., Asaka, M., 2005. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand. J. Gastroenterol. 40, 1321–1327. https://doi.org/10.1080/00365520510023530
Petersen, P.S., Jin, C., Madsen, A.N., Rasmussen, M., Kuhre, R., Egerod, K.L., Nielsen, L.B., Schwartz, T.W., Holst, B., 2011. Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism. FASEB J. 25, 3803–3814. https://doi.org/10.1096/fj.11-184531
Peukert, S., Hughes, R., Nunez, J., He, G., Yan, Z., Jain, R., Llamas, L., Luchansky, S., Carlson, A., Liang, G., Kunjathoor, V., Pietropaolo, M., Shapiro, J., Castellana, A., Wu, X., Bose, A., 2014. Discovery of 2-pyridylpyrimidines as the first orally bioavailable GPR39 agonists. ACS Med. Chem. Lett. 5, 1114–1118. https://doi.org/10.1021/ml500240d
Possamai, L.A., Antoniades, C.G., Anstee, Q.M., Quaglia, A., Vergani, D., Thursz, M., Wendon, J., 2010. Role of monocytes and macrophages in experimental and human acute liver failure. World J. Gastroenterol. 16, 1811–1819. https://doi.org/10.3748/wjg.v16.i15.1811
Prasad, A.S., 1998. Zinc in human health: An update. J. Trace Elem. Exp. Med. 11, 63–87. https://doi.org/10.1002/(SICI)1520-670X(1998)11:2/3<63::AID-JTRA2>3.0.CO;2-5
Ramachandran, G., 2014. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence 5, 213–218. https://doi.org/10.4161/viru.27024 Salomao, R., Karina, M., Brunialti, C., Rapozo, M.M., Baggio-zappia, G.L., Galanos, C., Freudenberg, M., 2012. Bacterial Sensing, Cell Signaling, and Modulation of the Immune Response During Sepsis. Shock 38, 227–242. https://doi.org/10.1097/SHK.0b013e318262c4b0
Sass, G., Heinlein, S., Agli, A., Bang, R., Schümann, J., Tiegs, G., 2002. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19, 115–120. https://doi.org/10.1006/cyto.2002.1948
Sato, S., Huang, X.-P., Kroeze, W.K., Roth, B.L., 2016. Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc. Mol. Pharmacol. 90, 726–737. https://doi.org/10.1124/mol.116.106112
Shan, W., Qi, J., Li, C., Nie, X., 2019. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells. Arch. Biochem. Biophys. 677, 108164. https://doi.org/10.1016/j.abb.2019.108164
Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S.A., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J.T., Sahebkar, A., 2018. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425–6440. https://doi.org/10.1002/jcp.26429
Shukla, P., Rao, G.M., Pandey, G., Sharma, S., Mittapelly, N., Shegokar, R., Mishra, P.R., 2014. Therapeutic interventions in sepsis: Current and anticipated pharmacological agents. Br. J. Pharmacol. 171, 5011–5031. https://doi.org/10.1111/bph.12829
Siebler, J., Wirtz, S., Frenzel, C., Schuchmann, M., Lohse, A.W., Galle, P.R., Neurath, M.F., 2008. Cutting Edge: A Key Pathogenic Role of IL-27 in T Cell- Mediated Hepatitis. J. Immunol. 180, 30–33. https://doi.org/10.4049/jimmunol.180.1.30
Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G.R., Chiche, J., Coopersmith, C.M., Hotchkiss, R.S., Levy, M.M., Marshall, J.C., Martin, G.S., Opal, S.M., Rubenfeld, G.D., van der Poll, T., Vincent, J., Angus, D.C., 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810. https://doi.org/10.1001/jama.2016.0287.The
Starowicz, G., Jarosz, M., Frąckiewicz, E., Grzechnik, N., Ostachowicz, B., Nowak, G., Mlyniec, K., 2019. Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008. J. Affect. Disord. 245, 325–334. https://doi.org/10.1016/j.jad.2018.11.003
Sunuwar, L., Medini, M., Cohen, L., Sekler, I., Hershfinkel, M., 2016. The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis. Philos. Trans. R. Soc. B Biol. Sci. 371, 20150420. https://doi.org/10.1098/rstb.2015.0420
Tagawa, Y., Matthys, P., Heremans, H., Dillen, C., Zaman, Z., Iwakura, Y., Billiau, A., 2000. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice. J. Leukoc. Biol. 67,90–96.
Tagawa, Y., Sekikawa, K., Iwakura, Y., 1997. Suppression of concanavalin A-induced hepatitis in IFNgamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 159, 1418–1428. https://doi.org/10.4049/jimmunol.178.11.7385
Tiegs, G., Hentschel, J., Wendel, A., 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196–203. https://doi.org/10.1172/JCI115836
Wahl, C., Wegenka, U.M., Leithauser, F., Schirmbeck, R., Reimann, J., 2009. IL-22-Dependent Attenuation of T Cell-Dependent (ConA) Hepatitis in Herpes Virus Entry Mediator Deficiency. J. Immunol. 182, 4521–4528. https://doi.org/10.4049/jimmunol.0802810
Walsh, C.T., Sandstead, H.H., Prasad, A.S., Newberne, P.M., Fraker, P.J., 1994. Zinc: Health effects and research priorities for the 1990s. Environ. Health Perspect. 102, 5–46. https://doi.org/10.2307/3431820
Wang, H., Liu, M., Weng, S.-Y., Li, J.-J., Xie, C., He, H.-L., Guan, W., Yuan, Y.-S., Gao, J., 2012. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J. Gastroenterol. 18, 119–25. https://doi.org/10.3748/wjg.v18.i2.119
Wessels, I., Maywald, M., Rink, L., 2017. Zinc as a gatekeeper of immune function. Nutrients 9, 9–12. https://doi.org/10.3390/nu9121286
Xu, Y., Wang, M., Xie, Y., Jiang, Y., Liu, M., Yu, S., Wang, B., Liu, Q., 2019. Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells. Eur. J. Pharmacol. 858, 172451. https://doi.org/10.1016/j.ejphar.2019.172451
Zhang, J. V., Ren, P.-G., Avsian-Kretchmer, O., Luo, C.-W., Rauch, R., Klein, C., Hsueh, A.J.W., 2005. Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin’s Effects on Food Intake. Science (80-. ). 310, 996–999. https://doi.org/10.1126/science.1117255
Zhang, X., Goncalves, R., Mosser, D.M., 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 1–14. https://doi.org/10.1002/0471142735.im1401s83
Zhao, H., Qiao, J., Zhang, S., Zhang, H., Lei, X., Wang, X., Deng, Z., Ning, L., Cao, Y., Guo, Y., Liu, S., Duan, E., 2015. GPR39 marks specific cells within the sebaceous gland and contributes to skin wound healing. Sci. Rep. 5, 7913. https://doi.org/10.1038/srep07913
Zheng, Y., Guo, Z., He, W., Yang, Y., Li, Y., Zheng, A., Li, P., Zhang, Y., Ma, J., Wen, M., Yang, M., An, H., Ji, G., Yu, Y., 2012. Ephedrine hydrochloride protects mice from LPS challenge by promoting IL-10 secretion and inhibiting proinflammatory cytokines. Int. Immunopharmacol. 13, 46–53. https://doi.org/10.1016/j.intimp.2012.03.005
Zhou, Z., Wang, L., Song, Z., Saari, J.T., McClain, C.J., Kang, Y.J., 2004. Abrogation of Nuclear FactorκB Activation Is Involved in Zinc Inhibition of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Liver Injury. Am. J. Pathol. 164, 1547–1556. https://doi.org/10.1016/S0002-9440(10)63713-3
論文の公開元へ
